LNTH FY 2013 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

FY 2013 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$284M-1.5% YoY

Gross Profit

$77M27.3% margin

Operating Income

-$19M-6.7% margin

Net Income

-$62M-21.7% margin

EPS (Diluted)

$-3.34

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$21M

Stock-Based Comp.

$578,000

Balance Sheet

Total Assets

$261M

Total Liabilities

$497M

Stockholders' Equity

-$236M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$284M	$288M	-1.5%
Gross Profit	$77M	$75M	+2.9%
Operating Income	-$19M	-$750,000	-2418.8%
Net Income	-$62M	-$42M	-46.6%